Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro
Curcumin, a bioactive polyphenol, is known to have anticancer properties. In this study, the effectiveness of curcumin pretreatment as a strategy for radio-sensitizing glioblastoma cell lines was explored. For this, U87 and T98 cells were treated with curcumin, exposed to 2 Gy or 4 Gy of irradiation...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/647864cbaf384089830a4e5ade7c45c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:647864cbaf384089830a4e5ade7c45c9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:647864cbaf384089830a4e5ade7c45c92021-11-25T16:49:03ZCurcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro10.3390/biomedicines91115622227-9059https://doaj.org/article/647864cbaf384089830a4e5ade7c45c92021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1562https://doaj.org/toc/2227-9059Curcumin, a bioactive polyphenol, is known to have anticancer properties. In this study, the effectiveness of curcumin pretreatment as a strategy for radio-sensitizing glioblastoma cell lines was explored. For this, U87 and T98 cells were treated with curcumin, exposed to 2 Gy or 4 Gy of irradiation, and the combined effect was compared to the antiproliferative effect of each agent when given individually. Cell viability and proliferation were evaluated with the trypan blue exclusion assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The synergistic effects of the combination treatment were analyzed with CompuSyn software. To examine how the co-treatment affected different phases of cell-cycle progression, a cell-cycle analysis via flow cytometry was performed. Treatment with curcumin and radiation significantly reduced cell viability in both U87 and T98 cell lines. The combination treatment arrested both cell lines at the G2/M phase to a higher extent than radiation or curcumin treatment alone. The synergistic effect of curcumin when combined with temozolomide resulted in increased tumor cell death. Our results demonstrate for the first time that low doses of curcumin and irradiation exhibit a strong synergistic anti-proliferative effect on glioblastoma cells in vitro. Therefore, this combination may represent an innovative and promising strategy for the treatment of glioblastoma, and further studies are needed to fully understand the molecular mechanism underlying this effect.Vasiliki ZoiVasiliki GalaniEvrysthenis VartholomatosNatalia ZacharopoulouEftichia TsoumelekaGeorgios GkizasGeorgios BoziosPericles TsekerisIeremias ChousidisIoannis LeonardosAndreas G. TzakosAthanasios P. KyritsisGeorge A. AlexiouMDPI AGarticlecurcuminglioblastoma cellsradiationBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1562, p 1562 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
curcumin glioblastoma cells radiation Biology (General) QH301-705.5 |
spellingShingle |
curcumin glioblastoma cells radiation Biology (General) QH301-705.5 Vasiliki Zoi Vasiliki Galani Evrysthenis Vartholomatos Natalia Zacharopoulou Eftichia Tsoumeleka Georgios Gkizas Georgios Bozios Pericles Tsekeris Ieremias Chousidis Ioannis Leonardos Andreas G. Tzakos Athanasios P. Kyritsis George A. Alexiou Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
description |
Curcumin, a bioactive polyphenol, is known to have anticancer properties. In this study, the effectiveness of curcumin pretreatment as a strategy for radio-sensitizing glioblastoma cell lines was explored. For this, U87 and T98 cells were treated with curcumin, exposed to 2 Gy or 4 Gy of irradiation, and the combined effect was compared to the antiproliferative effect of each agent when given individually. Cell viability and proliferation were evaluated with the trypan blue exclusion assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The synergistic effects of the combination treatment were analyzed with CompuSyn software. To examine how the co-treatment affected different phases of cell-cycle progression, a cell-cycle analysis via flow cytometry was performed. Treatment with curcumin and radiation significantly reduced cell viability in both U87 and T98 cell lines. The combination treatment arrested both cell lines at the G2/M phase to a higher extent than radiation or curcumin treatment alone. The synergistic effect of curcumin when combined with temozolomide resulted in increased tumor cell death. Our results demonstrate for the first time that low doses of curcumin and irradiation exhibit a strong synergistic anti-proliferative effect on glioblastoma cells in vitro. Therefore, this combination may represent an innovative and promising strategy for the treatment of glioblastoma, and further studies are needed to fully understand the molecular mechanism underlying this effect. |
format |
article |
author |
Vasiliki Zoi Vasiliki Galani Evrysthenis Vartholomatos Natalia Zacharopoulou Eftichia Tsoumeleka Georgios Gkizas Georgios Bozios Pericles Tsekeris Ieremias Chousidis Ioannis Leonardos Andreas G. Tzakos Athanasios P. Kyritsis George A. Alexiou |
author_facet |
Vasiliki Zoi Vasiliki Galani Evrysthenis Vartholomatos Natalia Zacharopoulou Eftichia Tsoumeleka Georgios Gkizas Georgios Bozios Pericles Tsekeris Ieremias Chousidis Ioannis Leonardos Andreas G. Tzakos Athanasios P. Kyritsis George A. Alexiou |
author_sort |
Vasiliki Zoi |
title |
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
title_short |
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
title_full |
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
title_fullStr |
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
title_full_unstemmed |
Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro |
title_sort |
curcumin and radiotherapy exert synergistic anti-glioma effect in vitro |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/647864cbaf384089830a4e5ade7c45c9 |
work_keys_str_mv |
AT vasilikizoi curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT vasilikigalani curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT evrysthenisvartholomatos curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT nataliazacharopoulou curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT eftichiatsoumeleka curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT georgiosgkizas curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT georgiosbozios curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT periclestsekeris curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT ieremiaschousidis curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT ioannisleonardos curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT andreasgtzakos curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT athanasiospkyritsis curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro AT georgeaalexiou curcuminandradiotherapyexertsynergisticantigliomaeffectinvitro |
_version_ |
1718412958463164416 |